-
(S)-(+)-Ibuprofen: From Stereochemistry to Assay Design
2026-09-15
(S)-(+)-Ibuprofen is a mechanistically informative COX inhibitor for separating stereochemical, enzymatic, cellular, and translational effects. This guide connects ibuprofen synthesis advances with assay design, concentration interpretation, and reproducibility decisions.
-
I-BET151 (GSK1210151A): Practical Research Guide
2026-09-15
I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor for controlled studies of BRD2, BRD3, and BRD4-dependent transcriptional responses. This guide covers formulation, assay setup, and quality control for cancer biology workflows, but the compound is for research use only and should not be treated as a diagnostic or therapeutic reagent.
-
Tropifexor (LJN452) for FXR Barrier Research
2026-09-14
Tropifexor (LJN452) combines subnanomolar FXR activity with a practical workflow for organoid, epithelial-barrier, metabolic, and liver disease model studies. This article translates recent neonatal piglet and patient-derived organoid findings into assay design, dosing, quality control, and troubleshooting decisions.
-
PD 0332991: From G1 Arrest to Tumor Context
2026-09-14
PD 0332991 (Palbociclib HCl) is more than a selective CDK4/6 inhibitor: its effects depend on Rb status, tumor lineage, and assay endpoints. This article connects cell-cycle pharmacology with recent pancreatic cancer evidence to guide more informative tumor growth suppression studies.
-
Anagliptin (SK-0403): Assay Reliability Guide
2026-09-13
A scenario-based guide for using Anagliptin (SK-0403), SKU BA7300, in cell viability, metabolic, and vascular mechanism studies. It connects DPP-4 inhibition with Kv channel modulation and SERCA pump regulation while emphasizing stock preparation, controls, interpretation, and practical product selection.
-
NO–S-nitrosylation Coordinates Al Resistance
2026-09-12
A 2026 Molecular Plant study identifies nitric oxide-dependent S-nitrosylation as a coordinated regulator of external and internal aluminum detoxification in Arabidopsis. By modifying STOP1 and STAR1 in opposite ways, NO balances malate-mediated exclusion with vacuolar sequestration, revealing why protein abundance alone does not predict aluminum resistance.
-
WST-8 Glucose Uptake Assay for CPP Delivery
2026-09-12
Use a non-radioactive 450 nm readout to determine whether ion-assisted CPP–nucleic acid delivery produces a meaningful metabolic response, not merely particle internalization. This workflow combines formulation controls, glucose uptake phenotyping, and troubleshooting for cancer metabolism research, diabetes models, and broader cell-based studies.
-
WZ4003 Workflows for NUAK1/2 Inhibition
2026-09-11
WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase engagement with changes in migration, proliferation, invasion, and tau phosphorylation. This practical guide shows how to build orthogonal assays, interpret brain-slice responses, and troubleshoot formulation or selectivity problems.
-
Isochlorogenic Acid A Hydrogel for Wound Repair
2026-09-11
A 2026 study developed an amylopectin/carboxymethyl chitosan hydrogel containing Isochlorogenic acid A/Fe(III) co-assembled nanoparticles to address the compound’s poor water solubility and stability. The composite dressing combined antibacterial activity, favorable mechanical and swelling properties, enhanced cell migration, and improved wound-healing-associated inflammatory and vascular markers in preclinical assays.
-
ApexPrep DNA Plasmid Miniprep Kit Guide
2026-09-10
Learn how ApexPrep DNA Plasmid Miniprep Kit (SKU A5001) can reduce plasmid-related variability in cloning, sequencing, transformation, transfection, and cell-based viability workflows. The article connects alkaline lysis plasmid purification with practical AML research design while distinguishing product-supported claims from laboratory recommendations.
-
AMG 9810: TRPV1 Antagonist Research Guide
2026-09-10
AMG 9810 is a selective competitive TRPV1 antagonist for dissecting capsaicin, proton, heat, and endogenous-ligand responses. Its nanomolar activity, reported inhibition of calcium influx and CGRP release, and defined solvent guidance support controlled sensory neuron signaling studies and pain mechanism research.
-
Methicillin sodium salt in Reliable Assays
2026-09-09
Learn how Methicillin sodium salt, SKU C3238, can improve interpretation of bacterial challenge, cell viability, proliferation, and cytotoxicity workflows. This scenario-driven guide covers mechanism, MSSA/MRSA controls, concentration selection, stock preparation, assay compatibility, and practical vendor evaluation.
-
Tofacitinib (CP-690550) in RA Macrophages
2026-09-09
Tofacitinib (CP-690550) is an oral JAK pathway inhibitor used to study cytokine signaling, lymphocyte activation, and inflammatory macrophage states. In a 2026 rheumatoid arthritis study, it reduced GM-CSFRα and STAT5-associated inflammatory and mitochondrial abnormalities in GM-CSF-reprogrammed macrophages.
-
Docosahexaenoic Acid: Applied Research Workflows
2026-09-08
Build reproducible DHA experiments around controlled lipid dosing, orthogonal stress readouts, and careful handling of oxidation-prone solutions. This workflow connects neuroprotection research with comparative immune-lipid assays while clearly separating evidence for DHA from findings reported for arachidonic acid.
-
IGF2BP1–THBS1–TLR4 Axis in Pulmonary Fibrosis
2026-09-08
A 2025 study identifies an m6A-dependent IGF2BP1–THBS1–TLR4 pathway that links macrophage glycolytic reprogramming with fibrotic polarization in pulmonary fibrosis. Its knockdown, rescue, and metabolic experiments provide a mechanistic framework for interpreting how RNA stability and macrophage state contribute to bleomycin-induced lung injury.